ASHLEA HILL: Open Payments
NPI 1235413329 · RUSTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$26,061 in 172 payments from 22 companies in 2025. Trend: 2023 $42,724 · 2024 $41,338 · 2025 $26,061
Speaker / faculty: $17,548Food & beverage: $3,551Speaker / faculty: $2,548Travel & lodging: $2,369Education: $45
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 28 | $8,406 |
| SANOFI-AVENTIS U.S. LLC | 15 | $5,104 |
| Dexcom, Inc. | 22 | $3,907 |
| Lilly USA, LLC | 18 | $3,510 |
| SANOFI US SERVICES INC. | 1 | $2,660 |
| BETA BIONICS, INC. | 15 | $573 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $476 |
| Bayer Healthcare Pharmaceuticals Inc. | 21 | $424 |
| Corcept Therapeutics | 11 | $196 |
| CeQur Corporation | 1 | $169 |
Products named: Ozempic, TZIELD, DEXCOM G7 GSS (161), JARDIANCE, iLet Bionic Pancreas, Kerendia, Dexcom G6 Transmitter, Korlym.
Industry payments across LA — which companies pay providers there.
